TNF-alpha receptor 1 expression on acute myeloid leukemic blasts predicts differentiation into leukemic dendritic cells. 2004

I Houtenbos, and T M Westers, and T D de Gruijl, and R J Scheper, and G J Ossenkoppele, and A A van de Loosdrecht

UI MeSH Term Description Entries
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D003713 Dendritic Cells Specialized cells of the hematopoietic system that have branch-like extensions. They are found throughout the lymphatic system, and in non-lymphoid tissues such as SKIN and the epithelia of the intestinal, respiratory, and reproductive tracts. They trap and process ANTIGENS, and present them to T-CELLS, thereby stimulating CELL-MEDIATED IMMUNITY. They are different from the non-hematopoietic FOLLICULAR DENDRITIC CELLS, which have a similar morphology and immune system function, but with respect to humoral immunity (ANTIBODY PRODUCTION). Dendritic Cells, Interdigitating,Interdigitating Cells,Plasmacytoid Dendritic Cells,Veiled Cells,Dendritic Cells, Interstitial,Dendritic Cells, Plasmacytoid,Interdigitating Dendritic Cells,Interstitial Dendritic Cells,Cell, Dendritic,Cell, Interdigitating,Cell, Interdigitating Dendritic,Cell, Interstitial Dendritic,Cell, Plasmacytoid Dendritic,Cell, Veiled,Cells, Dendritic,Cells, Interdigitating,Cells, Interdigitating Dendritic,Cells, Interstitial Dendritic,Cells, Plasmacytoid Dendritic,Cells, Veiled,Dendritic Cell,Dendritic Cell, Interdigitating,Dendritic Cell, Interstitial,Dendritic Cell, Plasmacytoid,Interdigitating Cell,Interdigitating Dendritic Cell,Interstitial Dendritic Cell,Plasmacytoid Dendritic Cell,Veiled Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

I Houtenbos, and T M Westers, and T D de Gruijl, and R J Scheper, and G J Ossenkoppele, and A A van de Loosdrecht
September 1999, Blood,
I Houtenbos, and T M Westers, and T D de Gruijl, and R J Scheper, and G J Ossenkoppele, and A A van de Loosdrecht
January 2005, Cancer immunology, immunotherapy : CII,
I Houtenbos, and T M Westers, and T D de Gruijl, and R J Scheper, and G J Ossenkoppele, and A A van de Loosdrecht
May 2007, Leukemia,
I Houtenbos, and T M Westers, and T D de Gruijl, and R J Scheper, and G J Ossenkoppele, and A A van de Loosdrecht
April 2006, International journal of oncology,
I Houtenbos, and T M Westers, and T D de Gruijl, and R J Scheper, and G J Ossenkoppele, and A A van de Loosdrecht
December 2019, Proceedings of the National Academy of Sciences of the United States of America,
I Houtenbos, and T M Westers, and T D de Gruijl, and R J Scheper, and G J Ossenkoppele, and A A van de Loosdrecht
August 2004, Cancer research,
I Houtenbos, and T M Westers, and T D de Gruijl, and R J Scheper, and G J Ossenkoppele, and A A van de Loosdrecht
June 2009, Pathology oncology research : POR,
I Houtenbos, and T M Westers, and T D de Gruijl, and R J Scheper, and G J Ossenkoppele, and A A van de Loosdrecht
February 2005, International journal of hematology,
I Houtenbos, and T M Westers, and T D de Gruijl, and R J Scheper, and G J Ossenkoppele, and A A van de Loosdrecht
January 1993, Experimental cell research,
I Houtenbos, and T M Westers, and T D de Gruijl, and R J Scheper, and G J Ossenkoppele, and A A van de Loosdrecht
May 2012, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!